Intravenous lidocaine for post-operative pain relief after hand-assisted laparoscopic colon surgery: a randomized, placebo-controlled clinical trial - Scorecard - MDSpire

Intravenous lidocaine for post-operative pain relief after hand-assisted laparoscopic colon surgery: a randomized, placebo-controlled clinical trial

  • By

  • R. Tikuišis

  • P. Miliauskas

  • N. E. Samalavičius

  • A. Žurauskas

  • R. Samalavičius

  • V. Zabulis

  • September 13, 2013

  • 0 min

Share

Clinical Scorecard: Efficacy of Intravenous Lidocaine for Alleviating Post-Surgical Pain Following Hand-Assisted Laparoscopic Colon Surgery: A Randomized, Placebo-Controlled Study

At a Glance

CategoryDetail
ConditionPost-surgical pain following hand-assisted laparoscopic colon surgery
Key MechanismsIntravenous lidocaine provides analgesic, antihyperalgesic, and anti-inflammatory effects
Target PopulationAdult patients (18–75 years) undergoing elective hand-assisted laparoscopic colon resection for colon cancer
Care SettingPerioperative and post-operative care in surgical and anesthesia units

Key Highlights

  • IV lidocaine infusion reduces post-operative pain levels after hand-assisted laparoscopic colon surgery
  • Lidocaine administration facilitates earlier restoration of bowel function and shortens hospital stay
  • Standardized anesthesia with lidocaine bolus and continuous infusion was well tolerated and compared to placebo

Guideline-Based Recommendations

Diagnosis

  • Assess patients scheduled for hand-assisted laparoscopic colon surgery for eligibility including ASA score and absence of contraindications to lidocaine

Management

  • Administer IV lidocaine bolus (1.5 mg/kg, max 100 mg) before anesthesia induction
  • Continue IV lidocaine infusion at 2 mg/kg/h intraoperatively and 1 mg/kg/h postoperatively for 24 hours
  • Maintain standardized general anesthesia with fentanyl, propofol, rocuronium, and sevoflurane

Monitoring & Follow-up

  • Monitor intraoperative blood pressure and heart rate, maintaining within 20% of baseline
  • Adjust anesthesia depth using bispectral index between 40 and 60
  • Observe for lidocaine-related adverse effects and ensure continuous postoperative analgesia

Risks

  • Exclude patients with severe hepatic, renal, cardiac, respiratory, endocrine diseases, or allergy to local anesthetics
  • Avoid in patients with history of alcohol or drug addiction or preoperative analgesic use

Patient & Prescribing Data

Adults aged 18–75 years with colon cancer undergoing elective hand-assisted laparoscopic colon surgery

IV lidocaine reduces opioid requirements, improves pain control, accelerates bowel function recovery, and shortens hospital stay compared to placebo

Clinical Best Practices

  • Use a double-blinded, placebo-controlled approach to evaluate analgesic efficacy
  • Standardize anesthesia protocols to minimize confounding variables
  • Ensure continuous postoperative lidocaine infusion for 24 hours to maximize analgesic benefits
  • Employ experienced surgical teams for consistent operative technique
  • Exclude patients with contraindications to lidocaine to enhance safety

References

Original Source(s)

Related Content